MarkhamC.LukeMDPhD

Dermatology • Silver Spring, MD

Supervisory Physician, Division Director, U.S. Food and Drug Administration

Join to view full profile

Dr. Luke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Luke's full profile

Already have an account?

Office
10903 New Hampshire Ave
Building 75
Silver Spring, MD 20903
Phone+1 301-796-5556

Education & Training

National Institutes of Health Clinical CenterResidency, Dermatology, 1997 - 1999
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1995 - 1997
Johns Hopkins UniversityInternship, Internal Medicine, 1994 - 1995
Johns Hopkins University School of MedicineClass of 1994

Certifications & Licensure

MD State Medical License 1997 - 2026

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.
Mark Donnelly, Lanyan Fang, Rajanikanth Madabushi, Hao Zhu, Markham Luke
Clinical Pharmacology and Therapeutics. 2025-01-01
Quantitative volumetric photoacoustic assessment of vasoconstriction by topical corticosteroid application in mice skin.
Donggyu Kim, Joongho Ahn, Donghyun Kim, Jin Young Kim, Seungah Yoo
Photoacoustics. 2024-12-01
1 citations
Locally acting dermatology drug products: Pharmaco-analytic considerations for bioequivalence.
Markham C Luke
European Journal of Pharmaceutical Sciences. 2024-08-01

Journal Articles

Medication Cost‐Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long‐Acting Beta‐Agonist (LABA) Drug Products in the USA
Zhong Wang, Sharon Ahluwalia, Bryan Newman, Sneha Dhapare, Liang Zhao, Markham Luke, Therapeutic Innovation & Regulatory Science, 2/3/2022
Adverse Effects Lotrisone Cream on Infant
La Grenade L, Vega A, Luke MC, Pediatrics, 12/1/2000

Abstracts/Posters

Anti-epiligrin cicatricial pemphigoid (CP): Clinical and immunopathologic features of 21 patients
Lazarova, Z; Hsu, R; Darling, TN; Luke, MC; Yee, C; Yancey KB, Journal of Dermatological Science, 3/1/1998

Lectures

FDA Regulatory Science for Dermatologists
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

Innovation Dispatches from the AADApril 2nd, 2019
Tattoo Remorse? What You Need to Know About Erasing Your InkJuly 3rd, 2017

Professional Memberships

American Academy of Dermatology - AAD
Fellow

External Links

Current Biohttps://www.grxbiosims.org/speakers/markham-luke-m-d-phd/